Viridian Therapeutics, Inc.\DE (VRDN) Current Deferred Revenue (2020 - 2025)
Viridian Therapeutics, Inc.\DE (VRDN) reported Current Deferred Revenue of $288,000 for Q2 2025, unchanged from $288,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Current Deferred Revenue (2020 - 2025) Analysis & Trends
Dating back to Q4 2020, Viridian Therapeutics, Inc.\DE's Current Deferred Revenue record includes 19 quarters.
- Current Deferred Revenue has a four-year compound annual growth rate of -1.1% (FY2020 to FY2024).
- By year, Current Deferred Revenue came in at $288,000 in FY2023 (unchanged), $288,000 in FY2022 (-0.3%), $289,000 in FY2021 (-4.0%) and $301,000 in FY2020.
- Five-year quarterly Current Deferred Revenue spans a low of $288,000 in Q1 2021 and a high of $301,000 in Q4 2020.
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 0.0% (Q2 2025) to 4.0% (Q4 2021).
- Per Business Quant data, the three quarters before Q2 2025 came in at $288,000 (Q1 2025), $288,000 (Q4 2024) and $288,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.33 Bn | 2.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 288,000.00 |
| Mar 31, 2025 | 288,000.00 |
| Dec 31, 2024 | 288,000.00 |
| Sep 30, 2024 | 288,000.00 |
| Jun 30, 2024 | 288,000.00 |
| Mar 31, 2024 | 288,000.00 |
| Dec 31, 2023 | 288,000.00 |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | 288,000.00 |
| Mar 31, 2023 | 288,000.00 |
| Dec 31, 2022 | 288,000.00 |
| Sep 30, 2022 | 288,000.00 |
| Jun 30, 2022 | 288,000.00 |
| Mar 31, 2022 | 288,000.00 |
| Dec 31, 2021 | 289,000.00 |
| Sep 30, 2021 | 288,000.00 |
| Jun 30, 2021 | 288,000.00 |
| Mar 31, 2021 | 288,000.00 |
| Dec 31, 2020 | 301,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();